Second, MFN2 was proposed to directly assist in phosphatidylserine (PS) transfer from the ER into mitochondria, thus protecting against NAFLD (Hernández-Alvarez et al., 2019; Figure 3). This evidence concerns the gene MFN2 and metabolic dysfunction-associated steatotic liver disease.